Clinical trial
Study to Demonstrate Equivalent Efficacy and to Compare Safety of Biosimilar Etanercept (GP2015) and Enbrel (EGALITY)
The purpose of this study is to demonstrate equivalent efficacy of GP2015 and Enbrel� in patients with moderate to severe chronic plaque-type psoriasis with respect to PASI 75 response rate at Week 12.
| Category | Value |
|---|---|
| Study start date | 2013-06-24 |